Therefore, understanding the relationship between ADAM17 function and the JAK/STAT pathway in diabetes and neurodegenerative diseases can provide insights into potential therapeutic strategies targeting this interplay to alleviate disease symptoms and progression. This evidence concerns the gene SOAT1 and neurodegenerative disease.